Skip to main content
PE

Peptomyc

Barcelona, Spain
Last funding
$5.8M
Venture - Series UnknownMar 2026

Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.

About Peptomyc

How much funding has Peptomyc raised?

Peptomyc has raised $5.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2026.

Who are Peptomyc's investors?

Peptomyc's investors include European Innovation Council, European Commission, Centre for the Development of Industrial Technology (CDTI), EISMEA, Horizon 2020.

Where is Peptomyc headquartered?

Peptomyc is headquartered in Barcelona, Spain.

What does Peptomyc do?

Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.

What stage is Peptomyc at?

Peptomyc is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Peptomyc — Funding & Investors." VCBacked, March 24, 2026, https://www.vcbacked.co/company/peptomyc. Accessed November 13, 2026.
APA
VCBacked. (2026). Peptomyc — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/peptomyc
Wikipedia (cite web)
{{cite web |title=Peptomyc — Funding & Investors |url=https://www.vcbacked.co/company/peptomyc |website=VCBacked |access-date=November 13, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Peptomyc? Request a listing update

Founder contacts
m***@peptomyc.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →